“Ramucirumab binds only to human and non-human primate VEGFR2, thus a single species was used for the toxicological assessment of the antibody.”
✓ VerifiedFDA pharmacology/toxicology review, p. 18Source ↗
Why that species
Binds only human and non-human primate VEGFR2 (not mouse); comparable binding affinity in human and monkey
“The Cynomolgus monkey can be considered an appropriate nonclinical species for ramucirumab toxicity testing given the comparable binding affinity of ramucirumab to its receptor in humans and Cynomolgus monkeys, and the fact that pharmacological effects have been seen in this test species.”